<Record>
<Term>Velafermin</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Recombinant Fibroblast Growth Factor</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Response Modifier/Recombinant Growth Factor/Recombinant Fibroblast Growth Factor/Velafermin</ClassificationPath>
<BroaderTerm>Velafermin</BroaderTerm>
<BroaderTerm>Recombinant Fibroblast Growth Factor</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Biological Response Modifier</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<BroaderTerm>Recombinant Growth Factor</BroaderTerm>
<Synonym>CG53135</Synonym>
<Synonym>Recombinant FGF-20</Synonym>
<Synonym>Recombinant Human Fibroblast Growth Factor-20</Synonym>
<Synonym>Velafermin</Synonym>
<Description>A recombinant human fibroblast growth factor-20 (rhFGF-20) protein with pro-proliferative activity.  Velafermin stimulates DNA synthesis and cell proliferation, specifically promoting epithelial and mesenchymal cell proliferation, and may prevent radiation or chemotherapy-induced oral mucositis.</Description>
<Source>NCI Thesaurus</Source>
</Record>
